Objective: This study assessed possible institutional and patient-related factors influencing the delivery of postmenopausal osteoporosis (PMO) care and the diagnostic priority placed on addressing PMO, relative to other common medical conditions, by primary care house staff at our institution.
Methods: A questionnaire was designed and distributed to eligible house staff at our institution.
Results: Approximately 50% (n = 52) of the house staff participated. The supervising clinic attending, patients' lack of insurance, accessibility to medical care, comorbid conditions, and university formulary were reported to influence decisions regarding osteoporosis care. Osteoporosis was ranked 6th of 7 medical issues (hypertension, coronary artery disease, diabetes, hypercholesterolemia, adult immunizations, osteoporosis, thyroid disease) to address during a comprehensive medical visit.
Conclusions: Our institution's primary care house staff reported multiple influences on decision making regarding osteoporosis care, and an overall low priority to address this issue. Based on PMO's associated morbidity and mortality, primary care training programs are challenged to put resources toward optimizing house staff delivery of osteoporosis care.
* Multiple institutional and patient-related factors were reported to influence house staff decision-making regarding the delivery of osteoporosis care to their patients.
* Addressing postmenopausal osteoporosis at the initial or comprehensive visit relative to 6 other common medical conditions was given a low priority by primary care house staff.
* Based on the morbidity and mortality associated with postmenopausal osteoporosis, various institutional and socioeconomic factors should be modified to optimize decision making and treatment plans of physicians-in-training.
1.Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). JAMA 2001;286:2815–2822.
2.Gehlbach SH, Fournier M, Bigelow C. Recognition of osteoporosis by primary care physicians. Am J Public Health 2002;92:271–273.
3.Siris ES, Weiss TW, Barlas S, et al. Underuse of osteoporosis treatment in postmenopausal women at high risk for low trauma fracture. J Bone Miner Res 2003;18(Suppl 2):S380.
4.U.S. Department of Health and Human Services [home page on the Internet]: Bone health and osteoporosis: a report of the Surgeon General. Washington, DC, October 14, 2004. (Accessed February 10, 2005, at www.surgeongeneral.gov/library/bonehealth
5.Cummings SR, Melton LJ, Epidemiology and outcomes of osteoporotic fractures. Lancet2002;359:1761–1767.
6.National Osteoporosis Foundation: America's bone health: the state of osteoporosis and low bone mass in our nation. Washington, DC, 2002.
7.American Cancer Society: Breast cancer facts and figures 2001-2002. Atlanta, GA, 2002.
8.King AB, Saag KG, Burge RT, et al. Fracture reduction affects Medicare economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporosis Int 2005;16:1545–1557.
9.Centers for Medicare and Medicaid Services [home page on the Internet]: Non-HMO women age 65+ with mammography services paid by Medicare, 1999-2001. Washington, DC. (Accessed February 10, 2005 at www.cms.hhs.gov/preventiveservices/1b31.pdf
10.Chhabra A, McNearney T, Shepherd A, et al. Primary care resident evaluations for chronic health conditions: a failure to assess for osteoporosis. J Bone Miner Res 2002;17(Suppl):S204–S264.
11.Chhabra A, McNearney T, Shepherd A, et al. Low priority of diagnostic screening of osteoporosis by primary care residents. Arthritis Rheum 2002;46(Suppl):S97.
12.McNearney T, Shepherd A, Chhabra A, et al. Diagnosis and treatment of postmenopausal osteoporosis: factors influencing house staff decision-making in primary care clinics. Arthritis Rheum2003;48(Suppl):S634.
13.Cadarette S, Jaglal SB, Krieger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 2000;162:1289–1294.
14.Cadarette SM, Jaglal SB, Murray TM, et al. Evaluation of decision rules for referring women for bone densitometry by dual energy x-ray absorptiometry. JAMA 2001;286:57–63.
15.Fleiss JL. Categories. Statistical methods and proportions. New York, John Wiley, 2nd Ed, 1981, p218.
17.Mareiness DP. Decreasing GME training stress to foster residents' professionalism. Acad Med2004;79:825–831.
18.Orces CH, Casas C, Lee S, Garci-Cavazos R, et al. Determinants of osteoporosis prevention in low income Mexican-American women. South Med J 2003;96:458–464.
19.McLean AJ. Drug rationing in a teaching hospital. BMJ 1994;309:54.
20.Schumock GT, Walton SM, Park HY, et al. Factors that influence prescribing decisions. Ann Pharmacother 2004;38:557–562.
21.Stafford RS, Drieling RL, Hersh AL. National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. Arch Intern Med 2004;164:1525–1530.
22.Grima DT, Burge RT, Becker DL, et al. Short-term cost-effectiveness of bisphosphonate therapies for postmenopausal osteoporotic women at high risk of fracture. P&T 2002;27:448–455.
23.Pazirandeh M. Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management? J Contin Educ Health Prof 2002;22:142–151.
24.Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998;21:1387–1388.